| GOLDMAN SACHS EMERGING MARKETS EX-CHINA CORE EQUITY PORTFOLIO BASE (CLOSE) USD CAP | RVI EMERGENTES | 77,97% | · | · | · |
| FIDELITY FUNDS-ASIAN SPECIAL SITUATIONS Y-ACC-USD | RVI ASIA EX-JAPÓN SMALL/MID CAP | 77,93% | 104,44% | 57,00% | 196,08% |
| FIDELITY FUNDS-ASIAN SPECIAL SITUATIONS Y-ACC-EUR | RVI ASIA EX-JAPÓN SMALL/MID CAP | 77,91% | 102,99% | 56,92% | · |
| JANUS HENDERSON HF - BIOTECHNOLOGY IU2 EUR HEDGED | RVI BIOTECNOLOGÍA | 77,65% | 96,37% | 91,09% | · |
| ALLIANZ CHINA A-SHARES AT EUR | RVI CHINA | 77,49% | 62,75% | · | · |
| ALLIANZ CHINA A-SHARES AT USD | RVI CHINA | 77,32% | 62,27% | -6,66% | · |
| AB SICAV I-INTERNATIONAL TECHNOLOGY PORTFOLIO S1 USD | RVI TECNOLOGÍA | 77,14% | 171,95% | 136,85% | 879,20% |
| T.ROWE CHINA EVOLUTION EQUITY FUND A | RVI CHINA | 77,07% | 84,72% | 23,64% | · |
| T.ROWE CHINA EVOLUTION EQUITY FUND A (HKD) | RVI CHINA | 77,06% | 84,81% | 23,65% | · |
| AB SICAV I-INTERNATIONAL TECHNOLOGY PORTFOLIO S1 EUR | RVI TECNOLOGÍA | 76,95% | 169,85% | 136,69% | 880,52% |
